Results 151 to 160 of about 23,408 (219)

Rhizobacteria‐Induced Systemic Priming Against Fungal Pathogens Involves Hydroxycinnamic Acid Amides

Plant, Cell &Environment, Volume 49, Issue 8, Page 4907-4921, August 2026.
ABSTRACT The rhizosphere, a narrow region of soil surrounding roots, contains diverse microorganisms with a composition that is distinct from the surrounding soil. Some rhizosphere bacteria can trigger a heightened state of immunity in the whole plant, termed Induced Systemic Resistance (ISR).
Mackenzie Eli William Loranger, Wolfgang Moeder, Hyunsuh Lee, David K. Liscombe, Eric Déziel, Keiko Yoshioka   +5 more
wiley   +1 more source

Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment. [PDF]

RSC Adv
Benny F, Oh JM, Kumar S, Abdelgawad MA, Ghoneim MM, Abdel-Bakky MS, Kukerti N, Jose J, Kim H, Mathew B.   +9 more
europepmc   +1 more source

Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart

The Journal of Physiology, Volume 604, Issue 15, Page 6281-6301, 1 August 2026.
Abstract figure legend The β1‐adrenergic receptor is the predominant adrenergic subtype expressed on cardiac myocytes. Upon stimulation it activates downstream signalling pathways that increase the heart rate and cardiac output to meet metabolic demands.
Parham Diba, Peter R. Levasseur, Samuel D. Newton, Khia Min Sabrina Koh, Paige C. Arneson‐Wissink, Xinxia Zhu, Peter Pham, Heike Mendez, Luke Whitcomb, Ariana Sattler, William R Woodward, Beth A. Habecker, Daniel L. Marks, Aaron J. Grossberg   +13 more
wiley   +1 more source

Electroconvulsive therapy and monoamine oxidase inhibitors Eletroconvulsoterapia e inibidores da monoaminoxidase

Brazilian Journal of Psychiatry, 2008
Rafael Bernardon Ribeiro, Moacyr Alexandro Rosa, Sérgio Paulo Rigonatti   +2 more
doaj   +1 more source

Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation. [PDF]

Molecules, 2019
Wang D, Hong RY, Guo M, Liu Y, Chen N, Li X, Kong DX.   +6 more
europepmc   +1 more source

Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor. [PDF]

Gen Hosp Psychiatry, 2018
Katz RB, Toprak M, Wilkinson ST, Sanacora G, Ostroff R.   +4 more
europepmc   +1 more source

Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders. [PDF]

Mar Drugs, 2019
Seong SH, Paudel P, Choi JW, Ahn DH, Nam TJ, Jung HA, Choi JS.   +6 more
europepmc   +1 more source

Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches.

Medchemcomm, 2019
Hong R, Li X.
europepmc   +1 more source

Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors. [PDF]

Medchemcomm, 2018
Mathew B, Baek SC, Grace Thomas Parambi D, Pil Lee J, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H.   +13 more
europepmc   +1 more source

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. [PDF]

Int J Neuropsychopharmacol, 2015
Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH.   +10 more
europepmc   +1 more source